Watford M, Smith E M, Erbelding E J
Biochem J. 1984 Nov 15;224(1):207-14. doi: 10.1042/bj2240207.
The activity of phosphate-activated glutaminase was increased in the kidney, liver and small intestine of rats made diabetic for 6 days with injection of streptozotocin (75 mg/kg body wt.). Insulin prevented this increase in all three tissues. Treatment with NaHCO3, to correct the acidosis that accompanies diabetes, prevented the increase in renal glutaminase activity, but not that in liver or small intestine. Chemically induced acidosis (NH4Cl solution as drinking water) or alkalosis (NaHCO3 solution as drinking water) increased and decreased, respectively, glutaminase activity in the kidney, but were without significant effect on the activity in liver and small intestine. The increase in glutaminase activity in the small intestine during diabetes was due to an overall increase in the size of this organ, and was only detectable when activity was expressed in terms of whole organ, not mucosal scrapings or isolated enterocytes. Prolonged diabetes (40 days) resulted in an even greater increase in the size and glutaminase activity of the small intestine. Despite this marked increase in capacity for glutamine catabolism, arteriovenous-difference measurements showed a complete suppression of plasma glutamine utilization by the small intestine during diabetes, confirming the report by Brosnan, Man, Hall, Colbourne & Brosnan [(1983) Am. J. Physiol. 235, E261-E265].
给大鼠注射链脲佐菌素(75毫克/千克体重)使其患糖尿病6天,大鼠肾脏、肝脏和小肠中的磷酸激活谷氨酰胺酶活性增加。胰岛素可阻止这三种组织中该酶活性的增加。用碳酸氢钠治疗以纠正糖尿病伴随的酸中毒,可阻止肾脏谷氨酰胺酶活性增加,但不能阻止肝脏或小肠中该酶活性增加。化学诱导的酸中毒(氯化铵溶液作为饮用水)或碱中毒(碳酸氢钠溶液作为饮用水)分别使肾脏中谷氨酰胺酶活性增加或降低,但对肝脏和小肠中的酶活性无显著影响。糖尿病期间小肠中谷氨酰胺酶活性增加是由于该器官整体大小增加,且只有当以整个器官而非黏膜刮片或分离的肠细胞来表示活性时才可检测到。长期糖尿病(40天)导致小肠大小和谷氨酰胺酶活性进一步增加。尽管谷氨酰胺分解能力有如此显著增加,但动静脉差异测量显示糖尿病期间小肠对血浆谷氨酰胺的利用完全受到抑制,这证实了布罗斯南、曼、霍尔、科尔本和布罗斯南的报告[(1983年)《美国生理学杂志》235卷,E261 - E265页]。